Lantern Pharma (LTRN) Earnings Date, Estimates & Call Transcripts $3.55 -0.17 (-4.57%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$3.62 +0.07 (+2.08%) As of 03/28/2025 07:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lantern Pharma Latest Earnings SummaryUpcoming Q1 Earnings DateMay. 8After Market ClosesEstimatedActual EPS (Mar. 27) -$0.54 Missed By -$0.03 Consensus EPS (Mar. 27) -$0.51 Lantern Pharma announced Q4 2024 earnings on March 27, 2025, reporting an EPS of -$0.54, which missed analysts' consensus estimates of -$0.51 by $0.03. With a trailing EPS of -$1.93, Lantern Pharma's earnings are expected to grow next year, from ($1.90) to ($1.86) per share. Conference CallConference Call TranscriptLTRN Upcoming EarningsLantern Pharma's next earnings date is estimated for Thursday, May 8, 2025, based off prior year's reporting schedules. Get Lantern Pharma Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lantern Pharma and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataLTRN Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.LTRN Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Remove Ads Lantern Pharma Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:($1.90) EPSNext Year EPS Consensus Estimate: ($1.86) EPS Remove Ads Lantern Pharma Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 5/8/2025(Estimated)-------3/27/2025Q4 2024-$0.51-$0.54 -$0.03-$0.54--11/7/2024Q3 2024-$0.56-$0.42+$0.14-$0.42--8/8/2024Q2 2024-$0.55-$0.46+$0.09-$0.46--5/9/2024Q1 2024-$0.43-$0.51 -$0.08-$0.51--3/18/2024Q4 2023-$0.40-$0.39+$0.01-$0.39--11/8/2023Q3 2023-$0.46-$0.29+$0.17-$0.29--8/9/2023Q2 2023-$0.40-$0.44 -$0.04-$0.44--5/9/2023Q1 2023--$0.36 -$0.36-$0.36-- Lantern Pharma Earnings - Frequently Asked Questions When is Lantern Pharma's earnings date? Lantern Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 8th, 2025 based off last year's report dates. Learn more on LTRN's earnings history. Did Lantern Pharma beat their earnings estimates last quarter? In the previous quarter, Lantern Pharma (NASDAQ:LTRN) missed the analysts' consensus estimate of ($0.51) by $0.03 with a reported earnings per share (EPS) of ($0.54). Learn more on analysts' earnings estimate vs. LTRN's actual earnings. How can I listen to Lantern Pharma's earnings conference call? The conference call for Lantern Pharma's latest earnings report can be listened to online. Listen to Conference Call How can I read Lantern Pharma's conference call transcript? The conference call transcript for Lantern Pharma's latest earnings report can be read online. Read Transcript How much profit does Lantern Pharma generate each year? Lantern Pharma (NASDAQ:LTRN) has a recorded net income of -$15.96 million. LTRN has generated -$1.93 earnings per share over the last four quarters. What is Lantern Pharma's EPS forecast for next year? Lantern Pharma's earnings are expected to grow from ($1.90) per share to ($1.86) per share in the next year. More Earnings Resources from MarketBeat Related Companies LYEL Earnings Results IKT Earnings Results ADCT Earnings Results MOLN Earnings Results CYBN Earnings Results CCCC Earnings Results SCPH Earnings Results HURA Earnings Results GLSI Earnings Results LRMR Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Intuitive Machines Gains After Earnings Beat, NASA Missions AheadNike Stock Dips on Earnings: Analysts Weigh in on What’s NextAfter Massive Post Earnings Fall, Does Hope Remain for MongoDB?Semtech Rallies on Earnings Beat—Is There More Upside?These 3 Q1 Earnings Winners Will Go HigherWhat Is the Price-to-Earnings (P/E) Ratio?Analysts Lift Archer Aviation Stock Despite Earnings Miss Remove Ads This page (NASDAQ:LTRN) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lantern Pharma Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lantern Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
